Keyphrases
In Vivo Model
100%
Type I IFN
100%
Protective Immunity
100%
Wild Mice
100%
Virus
100%
Zika Virus Infection
100%
Adaptive Immune Response
66%
Zika Virus
66%
Fatal Outcome
33%
Microcephaly
33%
Natural Immunity
33%
Effector Memory T Cells
33%
Antibody Level
33%
CD8+ T Cells
33%
Preventive Vaccine
33%
Immune Response
33%
Infectious Complications
33%
Cell Depletion
33%
Immunoblot Analysis
33%
Vaccine Design
33%
Specific Antibodies
33%
Virus Replication
33%
Protective Factors
33%
Humoral Immunity
33%
Neurological Complications
33%
Antibody-based
33%
Peripheral Organs
33%
Gene Targeting
33%
Fetus
33%
Nave
33%
Adoptive Transfer
33%
Small Animal Model
33%
Reinfection
33%
Encephalitis
33%
Guillain-Barré Syndrome
33%
Vaccine Development
33%
Biochemistry, Genetics and Molecular Biology
Zika virus
100%
Interferon Type I
100%
Wild Type Mouse
60%
Low Drug Dose
40%
CD8
40%
Adaptive Immunity
40%
T Cell
40%
Innate Immunity
20%
Antibody
20%
Virus Replication
20%
Immune Response
20%
Gene Targeting
20%
Humoral Immunity
20%
Animal Model
20%
Neuroscience
Interferon
100%
In Vivo
100%
Acquired Immunity
40%
T Cell
40%
CD8
40%
Encephalitis
20%
Antibody
20%
Gene Delivery
20%
Microcephaly
20%
Humoral Immunity
20%
Immunology and Microbiology